0001415889-22-000439.txt : 20220106
0001415889-22-000439.hdr.sgml : 20220106
20220106184824
ACCESSION NUMBER: 0001415889-22-000439
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20220104
FILED AS OF DATE: 20220106
DATE AS OF CHANGE: 20220106
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Xu Yuan
CENTRAL INDEX KEY: 0001858214
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-40925
FILM NUMBER: 22516086
MAIL ADDRESS:
STREET 1: C/O AKERO THERAPEUTICS, INC.
STREET 2: 601 GATEWAY BOULEVARD, SUITE 350
CITY: SOUTH SAN FRANCISCO
STATE: CA
ZIP: 94080
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Xilio Therapeutics, Inc.
CENTRAL INDEX KEY: 0001840233
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 851623397
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 828 WINTER STREET
CITY: WALTHAM
STATE: MA
ZIP: 02451
BUSINESS PHONE: 617-833-1027
MAIL ADDRESS:
STREET 1: 828 WINTER STREET
CITY: WALTHAM
STATE: MA
ZIP: 02451
4
1
form4-01062022_030116.xml
X0306
4
2022-01-04
0001840233
Xilio Therapeutics, Inc.
XLO
0001858214
Xu Yuan
C/O XILIO THERAPEUTICS, INC.
828 WINTER STREET, SUITE 300
WALTHAM
MA
02451
true
false
false
false
Stock Option (right to buy)
15.92
2022-01-04
4
A
0
26400
0
A
2032-01-03
Common Stock
26400
26400
D
The option award was granted on January 4, 2022 and will vest in three equal installments on January 4, 2023, January 4, 2024 and January 4, 2025.
/s/ Chris Frankenfield , Attorney-in-Fact
2022-01-06